Stomach Cancer Trial, Recruiting NCT07003334 Sponsor: Nanfang Hospital, Southern Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07003334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give their voluntary written agreement to participate in the trial
  • People aged between 18 and 75 years old (inclusive)
  • People of any sex
  • People who have been diagnosed with a type of stomach cancer called gastric adenocarcinoma, confirmed through a tissue sample taken during a stomach camera procedure (endoscopy), following a specific Japanese medical guideline for stomach cancer
  • People whose treating doctor has decided they need immune-based treatment (immune checkpoint inhibitor therapy) before surgery to remove the stomach cancer, followed by that surgery

Who may not be able to join:

  • Women who are currently pregnant or breastfeeding
  • People with serious mental illness
  • People who have previously had surgery on the upper abdomen, with the exception of keyhole surgery to remove the gallbladder
  • People with stomach cancer who do not wish to receive immune-based treatment before surgery
  • People who have been taking steroid medications continuously throughout the past month
  • People who currently have an active infection, an active or hard-to-treat immune system condition, or a serious ongoing illness affecting the whole body
  • People who the trial investigators determine are otherwise not suitable to participate, for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8615626452302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
3 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Tumor Regression Grade (TRG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov